BACKGROUND: Alcohol consumption has been comprehensively investigated as an etiologic risk factor for breast cancer but has received little attention in terms of its effect on prognosis after breast cancer, particularly for young women. METHODS: 1,286 women diagnosed with invasive breast cancer at age < or =45 years from two population-based case-control studies in the Seattle-Puget Sound region were followed from their diagnosis of breast cancer (between January 1983 and December 1992) for survival through June 2002, during which time 364 women had died. Cox proportional hazards modeling was used to assess the effect of prediagnostic alcohol consumption on the risk of dying. RESULTS: After adjusting for age and diagnosis year, compared with nondrinkers, women who consumed alcohol in the 5 years before diagnosis had a decreased risk of death [>0 to <3 drinks per week: hazard ratio, 0.7; 95% confidence interval (95% CI), 0.6-0.95; 3 to <7 drinks per week: risk ratio, 0.6; 95% CI, 0.4-0.8;7 drinks per week: risk ratio, 0.7; 95% CI, 0.5-0.9]. This association was unchanged on additional adjustment for potential confounders including most notably treatment, stage at diagnosis, and mammogram history. CONCLUSION: These results suggest that women who consume alcohol before a diagnosis of breast cancer have improved survival, which does not appear to be attributable to differences in stage, screening, or treatment.
BACKGROUND:Alcohol consumption has been comprehensively investigated as an etiologic risk factor for breast cancer but has received little attention in terms of its effect on prognosis after breast cancer, particularly for young women. METHODS: 1,286 women diagnosed with invasive breast cancer at age < or =45 years from two population-based case-control studies in the Seattle-Puget Sound region were followed from their diagnosis of breast cancer (between January 1983 and December 1992) for survival through June 2002, during which time 364 women had died. Cox proportional hazards modeling was used to assess the effect of prediagnostic alcohol consumption on the risk of dying. RESULTS: After adjusting for age and diagnosis year, compared with nondrinkers, women who consumed alcohol in the 5 years before diagnosis had a decreased risk of death [>0 to <3 drinks per week: hazard ratio, 0.7; 95% confidence interval (95% CI), 0.6-0.95; 3 to <7 drinks per week: risk ratio, 0.6; 95% CI, 0.4-0.8;7 drinks per week: risk ratio, 0.7; 95% CI, 0.5-0.9]. This association was unchanged on additional adjustment for potential confounders including most notably treatment, stage at diagnosis, and mammogram history. CONCLUSION: These results suggest that women who consume alcohol before a diagnosis of breast cancer have improved survival, which does not appear to be attributable to differences in stage, screening, or treatment.
Authors: S E Hankinson; W C Willett; G A Colditz; D J Hunter; D S Michaud; B Deroo; B Rosner; F E Speizer; M Pollak Journal: Lancet Date: 1998-05-09 Impact factor: 79.321
Authors: S A Smith-Warner; D Spiegelman; S S Yaun; P A van den Brandt; A R Folsom; R A Goldbohm; S Graham; L Holmberg; G R Howe; J R Marshall; A B Miller; J D Potter; F E Speizer; W C Willett; A Wolk; D J Hunter Journal: JAMA Date: 1998-02-18 Impact factor: 56.272
Authors: S Zhang; D J Hunter; S E Hankinson; E L Giovannucci; B A Rosner; G A Colditz; F E Speizer; W C Willett Journal: JAMA Date: 1999-05-05 Impact factor: 56.272
Authors: C A Swanson; R J Coates; K E Malone; M D Gammon; J B Schoenberg; D J Brogan; M McAdams; N Potischman; R N Hoover; L A Brinton Journal: Epidemiology Date: 1997-05 Impact factor: 4.822
Authors: Jeannette M Beasley; Polly A Newcomb; Amy Trentham-Dietz; John M Hampton; Andrew J Bersch; Michael N Passarelli; Crystal N Holick; Linda Titus-Ernstoff; Kathleen M Egan; Michelle D Holmes; Walter C Willett Journal: Breast Cancer Res Treat Date: 2011-01-01 Impact factor: 4.872
Authors: Marilyn L Kwan; Lawrence H Kushi; Erin Weltzien; Emily K Tam; Adrienne Castillo; Carol Sweeney; Bette J Caan Journal: J Clin Oncol Date: 2010-08-30 Impact factor: 44.544
Authors: Shirley W Flatt; Cynthia A Thomson; Ellen B Gold; Loki Natarajan; Cheryl L Rock; Wael K Al-Delaimy; Ruth E Patterson; Nazmus Saquib; Bette J Caan; John P Pierce Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-02-16 Impact factor: 4.254
Authors: Marilyn L Kwan; Wendy Y Chen; Shirley W Flatt; Erin K Weltzien; Sarah J Nechuta; Elizabeth M Poole; Michelle D Holmes; Ruth E Patterson; Xiao Ou Shu; John P Pierce; Bette J Caan Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-13 Impact factor: 4.254
Authors: Anne M Weaver; Susan E McCann; Jing Nie; Stephen B Edge; Thomas H Nochajski; Marcia Russell; Maurizio Trevisan; Jo L Freudenheim Journal: Breast Cancer Res Treat Date: 2013-04-19 Impact factor: 4.872
Authors: Polly A Newcomb; Ellen Kampman; Amy Trentham-Dietz; Kathleen M Egan; Linda J Titus; John A Baron; John M Hampton; Michael N Passarelli; Walter C Willett Journal: J Clin Oncol Date: 2013-04-08 Impact factor: 44.544
Authors: Alaa M G Ali; Marjanka K Schmidt; Manjeet K Bolla; Qin Wang; M Gago-Dominguez; J Esteban Castelao; Angel Carracedo; Victor Muñoz Garzón; Stig E Bojesen; Børge G Nordestgaard; Henrik Flyger; Jenny Chang-Claude; Alina Vrieling; Anja Rudolph; Petra Seibold; Heli Nevanlinna; Taru A Muranen; Kirsimari Aaltonen; Carl Blomqvist; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Akiyo Horio; Esther M John; Mark Sherman; Jolanta Lissowska; Jonine Figueroa; Montserrat Garcia-Closas; Hoda Anton-Culver; Mitul Shah; John L Hopper; Antonia Trichopoulou; Bas Bueno-de-Mesquita; Vittorio Krogh; Elisabete Weiderpass; Anne Andersson; Françoise Clavel-Chapelon; Laure Dossus; Guy Fagherazzi; Petra H Peeters; Anja Olsen; Gordon C Wishart; Douglas F Easton; Signe Borgquist; Kim Overvad; Aurelio Barricarte; Carlos A González; María-José Sánchez; Pilar Amiano; Elio Riboli; Tim Key; Paul D Pharoah Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-03-17 Impact factor: 4.254